Abstract: Nanoparticles have important biomedical applications ranging from the treatment of human disease with gene therapy to understanding basic cellular functions with fluorescent probes. It is now possible to synthesize nanoparticles with nearly any property or size, direct them to specific cells, and functionalize them to target intracellular locations, but delivering nanoparticles across the plasma membrane to reach their targets remains a challenge. We have recently demonstrated the first method for non-invasive delivery of semiconductor nanoparticles, known as quantum dots (QDs), to the cytosol of multiple cells simultaneously. Delivery requires pyrenebutyrate in combination with a cationic peptide for direct interaction of the QD with the plasma membrane. The ability of QDs to cross the plasma membrane offers exciting possibilities for the delivery of other nanoparticles to living cells. The first goal of this research program is to determine the molecular and cellular mechanism of pyrenebutyrate-mediated delivery and extend it to other nanoparticles with the ultimate goal of targeting specific intracellular sites with nanoparticles of choice. Novel imaging methods, including single particle tracking fluorescence microscopy, will be used to probe the motion of the nanoparticle and its interaction with pyrenebutyrate as it moves across the plasma membrane and through the cytosol. As pyrenebutyrate-mediated delivery may not be suitable for all nanoparticles and all applications, we will also work to develop a suite of cytosolic delivery and targeting methods that are based on the well-characterized endosomal uptake pathways. Both delivery methods will be carried out in conjunction with studies of cellular response to nanoparticles that aim to optimize delivery and minimize disruption. In the course of this research, QDs, which are sufficiently bright for imaging at the single particle level, will be used to probe fundamental questions of cellular transport including diffusion through the crowded cellular environment, vesicle-mediated transport, and nuclear targeting. Public Health Relevance: This research addresses a fundamental challenge in the use of nanotechnology for the benefit of human health;the delivery of nanoparticles into living cells. Two delivery methods, translocation and endocytosis, will be explored in conjunction with studies of cellular response for optimal delivery and minimal disruption. These studies will use a modular scheme for functionalization that can be extended to a wide variety of nanoparticles for broad impact in many different disciplines including cancer therapy, gene delivery, and cellular imaging.

Agency
National Institute of Health (NIH)
Institute
Office of The Director, National Institutes of Health (OD)
Type
NIH Director’s New Innovator Awards (DP2)
Project #
1DP2OD006470-01
Application #
7847984
Study Section
Special Emphasis Panel (ZGM1-NDIA-O (02))
Program Officer
Basavappa, Ravi
Project Start
2009-09-30
Project End
2014-06-30
Budget Start
2009-09-30
Budget End
2014-06-30
Support Year
1
Fiscal Year
2009
Total Cost
$2,265,000
Indirect Cost
Name
Georgia Institute of Technology
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
097394084
City
Atlanta
State
GA
Country
United States
Zip Code
30332
Wilder, Catera L; Walton, Charlene; Watson, Valencia et al. (2016) Differential cathepsin responses to inhibitor-induced feedback: E-64 and cystatin C elevate active cathepsin S and suppress active cathepsin L in breast cancer cells. Int J Biochem Cell Biol 79:199-208
Warren, Emilie A K; Payne, Christine K (2015) Cellular binding of nanoparticles disrupts the membrane potential. RSC Adv 5:13660-13666
Fleischer, Candace C; Payne, Christine K (2014) Nanoparticle-cell interactions: molecular structure of the protein corona and cellular outcomes. Acc Chem Res 47:2651-9
Fleischer, Candace C; Payne, Christine K (2014) Secondary structure of corona proteins determines the cell surface receptors used by nanoparticles. J Phys Chem B 118:14017-26
Hill, Alexandra; Payne, Christine K (2014) Impact of Serum Proteins on MRI Contrast Agents: Cellular Binding and T2 relaxation. RSC Adv 4:31735-31744
Bandyopadhyay, Debjyoti; Cyphersmith, Austin; Zapata, Jairo A et al. (2014) Lysosome transport as a function of lysosome diameter. PLoS One 9:e86847
Shin, Edwin H; Li, Ye; Kumar, Umesh et al. (2013) Membrane potential mediates the cellular binding of nanoparticles. Nanoscale 5:5879-86
Fleischer, Candace C; Kumar, Umesh; Payne, Christine K (2013) Cellular Binding of Anionic Nanoparticles is Inhibited by Serum Proteins Independent of Nanoparticle Composition. Biomater Sci 1:975-982
Doorley, Gerard W; Payne, Christine K (2012) Nanoparticles act as protein carriers during cellular internalization. Chem Commun (Camb) 48:2961-3
Fleischer, Candace C; Payne, Christine K (2012) Nanoparticle surface charge mediates the cellular receptors used by protein-nanoparticle complexes. J Phys Chem B 116:8901-7

Showing the most recent 10 out of 14 publications